These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7508668

  • 1. Effects of low doses of aprotinin on clotting times activated with celite and kaolin.
    Farooqi N, De Hert S, Vlaeminck R, De Bakker A, Govaerts E, Vermeyen K.
    Acta Anaesthesiol Belg; 1993; 44(3):87-92. PubMed ID: 7508668
    [Abstract] [Full Text] [Related]

  • 2. In vitro effects of aprotinin on activated clotting time measured with different activators.
    Wang JS, Lin CY, Hung WT, Thisted RA, Karp RB.
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1135-40. PubMed ID: 1383640
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro.
    Despotis GJ, Filos KS, Levine V, Alsoufiev A, Spitznagel E.
    Anesth Analg; 1996 Jun; 82(6):1126-31. PubMed ID: 8638779
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices.
    Dalbert S, Ganter MT, Furrer L, Klaghofer R, Zollinger A, Hofer CK.
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858
    [Abstract] [Full Text] [Related]

  • 11. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK.
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004 Aug; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 16. The activated clotting time in cardiac surgery: should Celite or kaolin be used?
    De Vries AJ, Lansink-Hartgring AO, Fernhout FJ, Huet RCG, van den Heuvel ER.
    Interact Cardiovasc Thorac Surg; 2017 Apr 01; 24(4):549-554. PubMed ID: 28108578
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of celite and kaolin on activated clotting time in the presence of aprotinin: activated clotting time is reduced by binding of aprotinin to kaolin.
    Dietrich W, Jochum M.
    J Thorac Cardiovasc Surg; 1995 Jan 01; 109(1):177-8. PubMed ID: 7529346
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.